Skip to content

SKYE · Skye Bioscience, Inc.

Healthcare · −2.5% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 15 feeds behind: Executive-branch trades, 8 days, and 14 more · Every feed →

On this page

The market view

Price chart

The interactive SKYE chart (by TradingView) loads here.

Our take

3 rules fired on SKYE

In short: none of these rules has solid or some evidence yet, so they show no clear lean on SKYE.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for SKYE, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on SKYE, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of SKYE. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 28, 2026–Oct 25, 2026 · UTC dates · today is excluded

Insider purchases

Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Oct 27, 2025Oct 25, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Aug 20, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 1. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 20260Partial; excluded
Aug 31, 2026–Sep 27, 20260Within stored history
Sep 28, 2026–Oct 25, 2026Latest period0Partial; excluded
Insider sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 9; range: 9–9.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 20269Partial; excluded
Aug 31, 2026–Sep 27, 20269Within stored history
Sep 28, 2026–Oct 25, 2026Latest period0Partial; excluded
Congress purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 2026—Unavailable
Aug 31, 2026–Sep 27, 2026—Unavailable
Sep 28, 2026–Oct 25, 2026Latest period—Unavailable
Congress sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 2026—Unavailable
Aug 31, 2026–Sep 27, 2026—Unavailable
Sep 28, 2026–Oct 25, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

Owners & lobbying · Oct 2026

  1. Filed
All 35 records in this snapshot
  1. Filed
  2. Disclosed
    5am Co-Investors II LP · Sale

    Transaction dated Sep 22, 2026

  3. Disclosed
    5am Co-Investors II LP · Sale

    Transaction dated Sep 23, 2026

  4. Disclosed
    5am Co-Investors II LP · Sale

    Transaction dated Sep 23, 2026

  5. Disclosed
    5AM Partners II, LLC · Sale

    Transaction dated Sep 22, 2026

  6. Disclosed
    5AM Partners II, LLC · Sale

    Transaction dated Sep 23, 2026

  7. Disclosed
    5AM Partners II, LLC · Sale

    Transaction dated Sep 22, 2026

  8. Disclosed
    5AM Partners II, LLC · Sale

    Transaction dated Sep 23, 2026

  9. Filed
  10. Disclosed
    5AM Partners VII, LLC · Sale

    Transaction dated Sep 22, 2026

  11. Disclosed
    5AM Ventures II LP · Sale

    Transaction dated Sep 23, 2026

  12. Disclosed
    5AM Ventures II LP · Sale

    Transaction dated Sep 22, 2026

  13. Disclosed
    5AM Ventures VII, L.P. · Sale

    Transaction dated Sep 23, 2026

  14. Disclosed
    5AM Ventures VII, L.P. · Sale

    Transaction dated Sep 22, 2026

  15. Disclosed
    5AM Ventures VII, L.P. · Sale

    Transaction dated Sep 22, 2026

  16. Disclosed
    5AM Ventures VII, L.P. · Sale

    Transaction dated Sep 23, 2026

  17. Disclosed
    Andrew J. Schwab · Sale

    Transaction dated Sep 23, 2026

  18. Disclosed
    Andrew J. Schwab · Sale

    Transaction dated Sep 23, 2026

  19. Disclosed
    Andrew J. Schwab · Sale

    Transaction dated Sep 22, 2026

  20. Disclosed
    John D Diekman · Sale

    Transaction dated Sep 22, 2026

  21. Disclosed
    John D Diekman · Sale

    Transaction dated Sep 23, 2026

  22. Disclosed
    John D Diekman · Sale

    Transaction dated Sep 23, 2026

  23. Disclosed
    Kush Parmar · Sale

    Transaction dated Sep 22, 2026

  24. Disclosed
    Kush Parmar · Sale

    Transaction dated Sep 22, 2026

  25. Disclosed
    Kush Parmar · Sale

    Transaction dated Sep 23, 2026

  26. Disclosed
    Scott M Rocklage · Sale

    Transaction dated Sep 22, 2026

  27. Disclosed
    Scott M Rocklage · Sale

    Transaction dated Sep 23, 2026

  28. Filed
  29. Filed
  30. Filed
  31. Filed
  32. Filed
  33. Filed
  34. Record date
  35. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on SKYE disclosed in the last 90 days.

See every Congress trade on SKYE →

Company insiders

0 buys · 27 sells (135 filed lots) · $4M sold

  1. ▼ SELL5AM Ventures VII, L.P. 10% ownerSKYE Skye Bioscience, Inc.$185Kdisclosed Sep 24 · filed 1 day after the trade
  2. ▼ SELL5AM Partners II, LLC 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  3. ▼ SELLKush Parmar 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  4. ▼ SELLScott M Rocklage 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  5. ▼ SELL5am Co-Investors II LP 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  6. ▼ SELLKush Parmar 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  7. ▼ SELL5AM Partners II, LLC 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  8. ▼ SELL5AM Partners II, LLC 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  9. ▼ SELL5AM Ventures II LP 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  10. ▼ SELL5AM Ventures VII, L.P. 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
See every insider trade on SKYE →

Big holders (Schedule 13D / 13G): 3 filings in the last 90 days · newest: Tang Capital Management LLC (13G), Oct 14, 2026 ↗

Filings & events

Company filings (8-K) 76

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Directors or officers joined, left or got new pay · item 5.0210
  • Shared information with investors · item 7.018
  • Other events · item 8.017
  • Signed a major agreement · item 1.017
  • Sold shares privately · item 3.025
  • Changed its charter or bylaws · item 5.034

Filing red flags 74

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 1

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Planned insider sales (Form 144) 4

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

None in the last 90 days · 4 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 6

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 4 filings
  • 13G, just holds: 2 filings

Filed most: 5AM Partners VII, LLC (4) · Tang Capital Management LLC (1) · Schonfeld Strategic Advisors LLC (1)

Biggest named funds (13F)

The largest SKYE holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on SKYE

  1. ▼ SELL5AM Ventures VII, L.P. 10% ownerSKYE Skye Bioscience, Inc.$185Kdisclosed Sep 24 · filed 1 day after the trade
  2. ▼ SELL5AM Partners II, LLC 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  3. ▼ SELLKush Parmar 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  4. ▼ SELLScott M Rocklage 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  5. ▼ SELL5am Co-Investors II LP 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  6. ▼ SELLKush Parmar 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  7. ▼ SELL5AM Partners II, LLC 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  8. ▼ SELL5AM Partners II, LLC 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  9. ▼ SELL5AM Ventures II LP 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  10. ▼ SELL5AM Ventures VII, L.P. 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  11. ▼ SELL5AM Partners II, LLC 10% ownerSKYE Skye Bioscience, Inc.$185Kdisclosed Sep 24 · filed 1 day after the trade
  12. ▼ SELLKush Parmar 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  13. ▼ SELLJohn D Diekman 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  14. ▼ SELLJohn D Diekman 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  15. ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$185Kdisclosed Sep 24 · filed 1 day after the trade
  16. ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  17. ▼ SELL5AM Ventures II LP 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  18. ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  19. ▼ SELL5AM Ventures VII, L.P. 10% ownerSKYE Skye Bioscience, Inc.$1.8Kdisclosed Sep 24 · filed 2 days after the trade
  20. ▼ SELL5am Co-Investors II LP 10% ownerSKYE Skye Bioscience, Inc.$185Kdisclosed Sep 24 · filed 1 day after the trade
  21. ▼ SELL5am Co-Investors II LP 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  22. ▼ SELL5AM Partners VII, LLC 10% ownerSKYE Skye Bioscience, Inc.$45.6Kdisclosed Sep 24 · filed 2 days after the trade
  23. ▼ SELL5AM Ventures VII, L.P. 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
  24. ▼ SELLJohn D Diekman 10% ownerSKYE Skye Bioscience, Inc.$185Kdisclosed Sep 24 · filed 1 day after the trade
  25. ▼ SELLScott M Rocklage 10% ownerSKYE Skye Bioscience, Inc.$7.3Kdisclosed Sep 24 · filed 1 day after the trade
See all 135 trades on SKYE →
People & votes

Which members of Congress traded SKYE, sponsored bills that touch it and voted on them — opens here.